87 related articles for article (PubMed ID: 26575121)
41. MicroRNA-218 promotes high glucose-induced apoptosis in podocytes by targeting heme oxygenase-1.
Yang H; Wang Q; Li S
Biochem Biophys Res Commun; 2016 Mar; 471(4):582-8. PubMed ID: 26876575
[TBL] [Abstract][Full Text] [Related]
42. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
43. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
44. Renal epithelial miR-205 expression correlates with disease severity in a mouse model of congenital obstructive nephropathy.
Wilhide ME; Feller JD; Li B; Mohamed AZ; Becknell B; Jackson AR; McHugh KM; Ingraham SE
Pediatr Res; 2016 Oct; 80(4):602-9. PubMed ID: 27384406
[TBL] [Abstract][Full Text] [Related]
45. Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic Rats.
Al-Trad B; Ashankyty IM; Alaraj M
Diabetol Metab Syndr; 2015; 7():97. PubMed ID: 26583047
[TBL] [Abstract][Full Text] [Related]
46. Divergent signaling via SUMO modification: potential for CFTR modulation.
Ahner A; Gong X; Frizzell RA
Am J Physiol Cell Physiol; 2016 Feb; 310(3):C175-80. PubMed ID: 26582473
[TBL] [Abstract][Full Text] [Related]
47. miR-181a-5p regulates the proliferation and apoptosis of glomerular mesangial cells by targeting KLF6.
Liang X; Xu W
Exp Ther Med; 2020 Aug; 20(2):1121-1128. PubMed ID: 32742352
[TBL] [Abstract][Full Text] [Related]
48. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
49. Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study.
Yu T; Xu B; Bao M; Gao Y; Zhang Q; Zhang X; Liu R
Front Endocrinol (Lausanne); 2022; 13():981100. PubMed ID: 36187128
[TBL] [Abstract][Full Text] [Related]
50. miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy.
Akpınar K; Aslan D; Fenkçi SM; Caner V
Diagnosis (Berl); 2022 Nov; 9(4):499-507. PubMed ID: 35976169
[TBL] [Abstract][Full Text] [Related]
51. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
[TBL] [Abstract][Full Text] [Related]
52. Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad Axis.
Deng B; Zhang J; Zhang X; Wang D; Cheng L; Su P; Yu T; Bao G; Li G; Hong L; Miao X; Yang W; Wang R; Xie J
ACS Pharmacol Transl Sci; 2024 Apr; 7(4):1126-1141. PubMed ID: 38633584
[TBL] [Abstract][Full Text] [Related]
53. Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy.
Tang S; An X; Sun W; Zhang Y; Yang C; Kang X; Sun Y; Jiang L; Zhao X; Gao Q; Ji H; Lian F
Front Endocrinol (Lausanne); 2024; 15():1336123. PubMed ID: 38419958
[TBL] [Abstract][Full Text] [Related]
54. The relevance of the non-invasive biomarkers lncRNA GAS5/miR-21 ceRNA regulatory network in the early identification of diabetes and diabetic nephropathy.
Sun H; Chen T; Li X; Zhu Y; Zhang S; He P; Peng Y; Fan Q
Diabetol Metab Syndr; 2023 Oct; 15(1):197. PubMed ID: 37821982
[TBL] [Abstract][Full Text] [Related]
55. Capturing the Kidney Transcriptome by Urinary Extracellular Vesicles-From Pre-Analytical Obstacles to Biomarker Research.
Barreiro K; Dwivedi OP; Rannikko A; Holthöfer H; Tuomi T; Groop PH; Puhka M
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510317
[TBL] [Abstract][Full Text] [Related]
56. The Link between Diabetes, Pancreatic Tumors, and miRNAs-New Players for Diagnosis and Therapy?
Kozłowska M; Śliwińska A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373398
[TBL] [Abstract][Full Text] [Related]
57. miR-372-3p is a potential diagnostic factor for diabetic nephropathy and modulates high glucose-induced glomerular endothelial cell dysfunction via targeting fibroblast growth factor-16.
Meng Z; Li F; Wang B
Arch Med Sci; 2023; 19(3):703-716. PubMed ID: 37313198
[TBL] [Abstract][Full Text] [Related]
58. Urinary microRNA in Diabetic Kidney Disease: A Literature Review.
Lee CC; Chen CC; Hsu CK; Chen YT; Chen CY; Yang KJ; Hung MJ; Wu IW
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837555
[TBL] [Abstract][Full Text] [Related]
59. The Versatile Role of miR-21 in Renal Homeostasis and Diseases.
Larrue R; Fellah S; Van der Hauwaert C; Hennino MF; Perrais M; Lionet A; Glowacki F; Pottier N; Cauffiez C
Cells; 2022 Nov; 11(21):. PubMed ID: 36359921
[TBL] [Abstract][Full Text] [Related]
60. MicroRNAs in kidney injury and disease.
Mahtal N; Lenoir O; Tinel C; Anglicheau D; Tharaux PL
Nat Rev Nephrol; 2022 Oct; 18(10):643-662. PubMed ID: 35974169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
